Deep, targeted next-era sequencing has uncovered that subclonal mutations (i.e., those current in just a fraction of tumor cells) is often detected for all driver genes and therefore are affiliated with speedy disorder progression and weak consequence.eleven–13 This is particularly pertinent for TP53 mutations supplied The point that, as explaine